SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-180804
Filing Date
2015-05-11
Accepted
2015-05-11 08:44:27
Documents
13
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d888694d10q.htm 10-Q 592866
2 EX-10.1 d888694dex101.htm EX-10.1 8692
3 EX-10.2 d888694dex102.htm EX-10.2 107660
4 EX-31.1 d888694dex311.htm EX-31.1 8610
5 EX-31.2 d888694dex312.htm EX-31.2 8584
6 EX-32.1 d888694dex321.htm EX-32.1 3898
7 EX-32.2 d888694dex322.htm EX-32.2 3929
  Complete submission text file 0001193125-15-180804.txt   4106774

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT cnce-20150331.xml EX-101.INS 435066
9 XBRL TAXONOMY EXTENSION SCHEMA cnce-20150331.xsd EX-101.SCH 40204
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cnce-20150331_cal.xml EX-101.CAL 56010
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cnce-20150331_def.xml EX-101.DEF 134605
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE cnce-20150331_lab.xml EX-101.LAB 321279
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cnce-20150331_pre.xml EX-101.PRE 249232
Mailing Address 99 HAYDEN AVENUE SUITE 500 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE SUITE 500 LEXINGTON MA 02421 781-860-0045
CONCERT PHARMACEUTICALS, INC. (Filer) CIK: 0001367920 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36310 | Film No.: 15849019
SIC: 2834 Pharmaceutical Preparations